Morning Seminar May 24, 2006

Cancer. 2005 Oct 15;104(8):1661-7.

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.

Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA.